BTG Pactual Asset Management US »

Amneal Pharmaceuticals shares owned by BTG Pactual Asset Management US

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by BTG Pactual Asset Management US from 13F filings

Historical chart of BTG Pactual Asset Management US investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by BTG Pactual Asset Management US consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by BTG Pactual Asset Management US

Quarter filed Position value Share count Share price at filing
2026-03-31 $221k 18k 12.43

More positions owned by BTG Pactual Asset Management US

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 1000 Grw Etf (IWF)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Totalenergies Se Act Call Option (TTE)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Spdr Gold Tr Gold Shs (GLD)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)

View all positions for BTG Pactual Asset Management US

Top funds holding Amneal Pharmaceuticals

BlackRock
Vanguard Group
Tpg Gp A
Vanguard Portfolio Management
Rubric Capital Management
Vanguard Capital Management
Dimensional Fund Advisors
Morgan Stanley
Geode Capital Management
State Street Corporation
Neuberger Berman Group
Nuveen
Invesco
Assenagon Asset Management
Goldman Sachs Group

View all funds holding Amneal Pharmaceuticals